CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 4, 2026, 10:52 AM EST
CNBX Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
112.58K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | - | - | - |
| Aug 31, 2024 | 130.07K | -280.09K | -68.29% |
| Aug 31, 2023 | 410.17K | 380.21K | 1,269.13% |
| Aug 31, 2022 | 29.96K | - | - |
| Aug 31, 2021 | - | - | - |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endonovo Therapeutics | 255.72K |
| Regen BioPharma | 236.56K |
| GB Sciences | 97.24K |
| U.S. Stem Cell | 82.05K |
| Affymax | 42.00K |